Sign In

Ulrich Muehlner

Global Head Corporate Strategy a.i. at Novartis

Ulrich Muehlner is a highly accomplished professional with extensive experience in corporate strategy and planning. He currently holds the position of Global Head Corporate Strategy a.i. at Novartis, as indicated by his LinkedIn username ulrichmuehlner.

In addition to his role at Novartis, Muehlner is also involved in several entrepreneurial ventures in the healthcare technology sector:

Co-founder and CEO of docdok.health

Ulrich Muehlner is the co-founder and CEO of docdok.health, a company that focuses on digitalizing the traditional physician-patient interface.12 The company aims to address major pain points in healthcare and enrich existing clinical processes through their universal docdok platform.2

Co-founder and Chairman of docjo.health

Muehlner also serves as the co-founder and Chairman of the Board at docjo.health, another healthcare technology company.34

Involvement in Healthcare Innovation

Ulrich Muehlner is actively involved in discussions and presentations about healthcare digitalization and innovation. He has participated in panel discussions on data-driven approaches in healthcare1 and is engaged in events related to digital health and healthcare innovation.4

His expertise and leadership in both corporate strategy and healthcare technology make him a notable figure in the industry, bridging the gap between traditional pharmaceutical companies and innovative digital health solutions.

Highlights

Jun 3 · linkedin

📅 One week to go ...

I am very much looking forward to the upcoming Open mic: Next in health series on the topic "Beyond the pill: Apps on prescription for better health" and to represent docjo.health and our innovative portfolio of #digitaltherapeutics for #chronicdiseases on stage and to discuss with my co-panelists:

Siro Gottardi Manuel Puntschuh Dr. Maren Schinz

Organized by DayOne - Healthcare Innovation and hosted by Switzerland Innovation Park Basel Area, this event brings together thought leaders, innovators and other healthcare stakeholders.

In this episode, you will:

✔️ Explore the evolution of apps on prescription ✔️ Learn about prescribed apps impact in medication adherence, treatment outcomes and satisfaction ✔️ Discuss how prescribed apps are revolutionizing the way patients adhere to treatment regimens, manage and treat their health conditions, and engage with their healthcare providers ✔️ Network and talk to global experts ✔️ Exchange ideas with like-minded professionals ✔️ Enjoy an Apéro at the Novartis Pavillon

👉 Sign up right here: https://lnkd.in/efHYsp9t (Note: On-site registration is already closed, but DM me in case you want to participate in person, otherwise please register for online participation)

Rahel Schneider Ursula Costa Morgane Husser Arianna Carolina R. Caoimhe Vallely-Gilroy

Oliver Felix Yves Nordmann Rebecca Szeinwald Klara Ullmann-Kurz

#Digitalhealth #Remotepatientmonitoring #Patientengagement

May 4 · linkedin

Petition (auf Deutsch) 'Die Sache der Ukraine ist auch unsere Sache!' Bitte lesen, unterschreiben und teilen

Petition (in German) 'Ukraine's matter is our matter too!' Please read, sign, and share

https://chng.it/HGgm8zfbmR

#weareallukrainians #westandwithukraine #putinisawarcriminal

Related Questions

What are Ulrich Muehlner's key achievements at Novartis?
How did Ulrich Muehlner contribute to docdok.health?
What is the docdok.health platform about?
What role does Ulrich Muehlner play at docjo.health?
Can you provide more details about the Baselhealthtech conference where Ulrich Muehlner was involved?
Ulrich Muehlner
Ulrich Muehlner, photo 1
Ulrich Muehlner, photo 2
Add to my network

Location

Basel, Basel, Switzerland